- Home
- CERO vs GITS Comparison
CERO vs GITS Comparison
Compare CERO & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- GITS
- Stock Information
- Founded
- CERO 2017
- GITS 2018
- Country
- CERO United States
- GITS South Korea
- Employees
- CERO N/A
- GITS N/A
- Industry
- CERO
- GITS
- Sector
- CERO
- GITS
- Exchange
- CERO Nasdaq
- GITS Nasdaq
- Market Cap
- CERO 6.1M
- GITS 7.0M
- IPO Year
- CERO N/A
- GITS N/A
- Fundamental
- Price
- CERO $5.39
- GITS $2.07
- Analyst Decision
- CERO Strong Buy
- GITS
- Analyst Count
- CERO 2
- GITS 0
- Target Price
- CERO $45.00
- GITS N/A
- AVG Volume (30 Days)
- CERO 82.8K
- GITS 16.8K
- Earning Date
- CERO 11-18-2025
- GITS 11-19-2025
- Dividend Yield
- CERO N/A
- GITS N/A
- EPS Growth
- CERO N/A
- GITS N/A
- EPS
- CERO N/A
- GITS N/A
- Revenue
- CERO N/A
- GITS $29.00
- Revenue This Year
- CERO N/A
- GITS N/A
- Revenue Next Year
- CERO N/A
- GITS N/A
- P/E Ratio
- CERO N/A
- GITS N/A
- Revenue Growth
- CERO N/A
- GITS N/A
- 52 Week Low
- CERO $4.27
- GITS $0.87
- 52 Week High
- CERO $895.40
- GITS $9.78
- Technical
- Relative Strength Index (RSI)
- CERO 40.84
- GITS 38.31
- Support Level
- CERO $5.18
- GITS $2.21
- Resistance Level
- CERO $5.45
- GITS $2.47
- Average True Range (ATR)
- CERO 0.24
- GITS 0.14
- MACD
- CERO 0.09
- GITS -0.03
- Stochastic Oscillator
- CERO 56.96
- GITS 2.97
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.